With over a century of combined experience, Outplay’s corporate team brings a range of broad and nuanced expertise to the organization.

Terrell Herring

Chief Executive Officer & Board of Directors

A distinguished and natural leader with more than 30 years of experience in the pharmaceutical industry, Terrell “Terry” Herring currently serves as the acting CEO of OPI.

Previously, Herring was President, Commercial Operations for Mission Pharmacal Company where he oversaw the transformation of this small pharmaceutical company to a well-respected conglomerate in the pharma industry with seven distinct subsidiaries operating under the “Mission Family of Companies” umbrella. Prior to Mission, Herring was President, Chief Operating Officer, and Director, at InVentiv Health. He first joined InVentiv Sales and Marketing in 1999 as a National Business Director and moved progressively through additional positions including Vice President and General Manager, as well as Vice President of Sales before being appointed President in 2002. Herring was the Senior National Sales Director with Noven Pharmaceuticals, where he was instrumental in establishing their first sales force and creating an effective team dedicated to transdermal delivery and women’s health marketing. He also held positions with Solvay Pharmaceuticals as a Regional Business Director, Director of Training and Development, Director of Operations and Trade Affairs, and Director of Customer Marketing. Prior to this, Herring served as Training Manager, Hospital Sales Manager, and Trade Relations Manager with Ciba-Geigy Pharmaceuticals.

In 2017, Herring was recognized by PharmaVOICE magazine as a Red Jacket honoree, the publication’s highest distinction for people in the pharmaceutical industry. Previously, he had been named by the publication as one of the industry’s 100 Most Inspiring people in both 2007 and 2008.

Herring serves on the board of directors for Bridging the Gap Africa, a nonprofit group that helps local communities in rural Kenya build life-saving footbridges across dangerous rivers to give residents safe access to education, healthcare, and economic opportunity. He is also on the board of directors for A New Equilibrium (ANE), the advisory board for BioAgilytix, and is a former Big Brother’s Big Sister’s Board Member (2007 honoree).

Herring graduated magna cum laude with a B.S. in biology from The Citadel, Military College of South Carolina. In addition, he attended Mercer University School of Engineering where he received a graduate certificate in project design and Duke University/London Business School where he earned a graduate certificate at the International Marketing Forum.

Jason Benge

Chief Financial Officer & Board of Directors

An accomplished executive, Jason Benge brings his pragmatic, astute, and insightful approach to his roles as Board Member and Chief Financial Officer of OPI.

As former Co-President of ABI Document Support Services, Benge was responsible for the company’s strategic direction and cutting-edge initiatives which led to their rapid and considerable growth and eventual sale to a public company.

Over the last thirty years, Benge has served on multiple boards of directors including EDCO, Inc. and ABI and is currently splitting time between Europe and the US managing existing and exploring new global investment opportunities.

Michael Cloutier

Board of Directors

Michale Cloutier is an accomplished business leader and consultant with over 39 years in the Life Sciences sector. Over the past 25 years, Mike was General Manager, President, and CEO of five major pharmaceutical firms and one Not-for-Profit organization, the Canadian Diabetes Association (now Diabetes Canada).

In 2017, Mike founded a Canadian-based global consulting practice, Accelera Canada Ltd. Accelera Canada provides unique and unparalleled “one-stop support” to US and European-based biotech/pharmaceutical companies exploring commercial entry to Canada. Most recently, Mike co-founded Novescend (Accelera MedTech Canada Inc.) to provide consultation, in-licensing, and distribution to US/EU-based medical device innovators.

Prior to his role at Accelera Canada, Mike led organizations with interests in the Orphan and Rare disease market segments. As the General Manager and President of PTC Therapeutics Canada and InterMune Canada Inc., he ensured the delivery of tremendous support to patients and caregivers. These companies drove exceptional results in terms of optimal access for patients in need and financial success.

Mike has held positions in Latin America and Europe, serving as Senior Director, Operations, Latin America/Canada and as the Vice-President, Human Resources – Global Marketing for AstraZeneca Inc.

Mike has been responsible for Life Cycle Management in several of his senior leadership roles. In Canada, as both a senior marketing leader and as CEO of a number of companies, he has been responsible for developing the strategy and ensuring excellence in the tactical implementation of plans for products in early, mid and late stages of their life cycle. He has engaged in many significant therapeutic classes including Oncology, Neuro-muscular, Cardiology, Gastroenterology, Infectious Disease, and Inflammation. Mike has also provided leadership on a global scale in the US, Europe, and Latin America.

His leadership in Operations and Global Marketing provided Mike with the opportunity to set clear direction in determining the breadth and depth of product portfolios at Searle and AstraZeneca.

Mike is active on a strategic level, sitting on and leading a variety of Boards. He sits on the Boards of ODAIA , OBIO, Arylide and Alimentiv. He has previously chaired the Board of Merus Labs International and was a Board Director at Joule, a subsidiary of the Canadian Medical Association. As a result, Mike has an extensive network throughout Canada, the US, and internationally.

Mike is a respected, dedicated philanthropist and has served on numerous Boards as a volunteer including the Canadian Stroke Network, Sheridan College Institute of Technology and Advanced Learning, and the Canadian Orthopaedic Foundation. Mike is the past Fundraising Chair of the Hazel McCallion Academic Learning Centre at the University of Toronto Mississauga.

Among his many accomplishments, Mike was inducted to the Sheridan College School of Business Marketing Hall of Fame and the Canadian Pharmaceutical Marketing Hall of Fame.

Amanda Wallace

Chief Operating Officer

With a reputation for being meticulous and energetic, Amanda Wallace comes from over a decade in management consulting and product management and currently serves as COO of OPI.

With expertise in business process strategy & planning, subscription and recurring revenue, merger & acquisition, technology solutions, and pricing & financial analysis across industries from SaaS / data services, business & financial services, media/entertainment, apparel/retail/eCommerce, and legal/insurance; Wallace brings a breadth of experience and perspective to OPI.

Wallace is a certified Project Management Professional (PMP®) and holds a B.S. in Business Administration from California State University, East Bay with options in Marketing and Corporate Management and a minor in Spanish.

Scientific Advisory Board

Brad Dieter, MS, PhD

Board Chair

An expert in physiology, molecular biology, and biomedical science, Brad Dieter recently finished his fellowship training in discovering novel therapeutics. Dr. Dieter’s research adopts a bench-to-bedside approach; adeptly utilizing molecular biology tools and his advanced training in biostatistics to discover and develop novel therapeutic agents for disease. In addition to his scientific career and training, he has been involved in building several businesses in the health-technology and biotechnology space through work as an executive and on scientific advisory boards.

Chad Macias, MSc

Chad Macias founded the Institute for Human Kinetics in 2011, where he works with many of the world’s top athletes. He has spent over 19 years conducting research and developing protocols in cellular and molecular physiology, developing some of the most advanced blood lactate testing and intermittent hypoxia protocols in the world. Macias has the experience and knowledge-base to conduct both medical and exercise physiology research and drives R&D at OPI.

Timothy Sharpe, MSc, DACM

A nutritionist and functional medicine practitioner, Tim Sharpe has fifteen years of clinical experience diagnosing and treating complex diseases. He currently serves as the head nutritionist at the Institute for Human Kinetics and is an adjunct faculty member in the post-graduate Human Nutrition and Functional Medicine program at the University of Western States where he teaches integrative therapies to physicians and allied health professionals.